218 related articles for article (PubMed ID: 36905443)
21. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
[TBL] [Abstract][Full Text] [Related]
22. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
23. Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy.
Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Califano G; Tian Z; Verze P; Shariat SF; Saad F; Briganti A; Mirone V; Karakiewicz PI
Eur Urol Focus; 2022 Mar; 8(2):498-505. PubMed ID: 33737024
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center Experience.
Park I; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Ahn H; Cho YM; Lee J; Hong B
Clin Genitourin Cancer; 2024 Jun; 22(3):102069. PubMed ID: 38580522
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
[TBL] [Abstract][Full Text] [Related]
26. Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.
Song W; Jeong JY; Jeon HG; Seo SI; Jeon SS; Choi HY; Lee HM; Sung HH
Int J Surg; 2019 Jun; 66():12-17. PubMed ID: 31018160
[TBL] [Abstract][Full Text] [Related]
27. Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756).
Calleris G; Rouprêt M; Seisen T; Bendjeddou L; Chevallier T; Masson-Lecomte A; Thibault C; Neuzillet Y; Audenet F; Xylinas E; Houédé N
World J Urol; 2023 Dec; 41(12):3413-3420. PubMed ID: 37698632
[TBL] [Abstract][Full Text] [Related]
28. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
Martini A; Lonati C; Nocera L; Fallara G; Raggi D; Herout R; Zamboni S; Ploussard G; Predere B; Mattei A; Simeone C; Krajewski W; Simone G; Soria F; Gontero P; Roupret M; Montorsi F; Briganti A; Shariat SF; Necchi A; Moschini M
Eur Urol Oncol; 2022 Aug; 5(4):451-459. PubMed ID: 35504834
[TBL] [Abstract][Full Text] [Related]
29. Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study.
Murakami Y; Matsumoto K; Ikeda M; Hirayama T; Utsunomiya T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M
Int J Clin Oncol; 2019 Nov; 24(11):1412-1418. PubMed ID: 31197556
[TBL] [Abstract][Full Text] [Related]
30. Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Takahashi K; Urabe F; Suhara Y; Nakano J; Yoshihara K; Goto Y; Sadakane I; Koike Y; Yata Y; Suzuki H; Kurawaki S; Miyajima K; Iwatani K; Imai Y; Sakanaka K; Nakazono M; Kurauchi T; Kayano S; Onuma H; Aikawa K; Yanagisawa T; Tashiro K; Tsuzuki S; Koike Y; Furuta A; Miki J; Kimura T
Jpn J Clin Oncol; 2023 Dec; 53(12):1208-1214. PubMed ID: 37647644
[TBL] [Abstract][Full Text] [Related]
31. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
32. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
[TBL] [Abstract][Full Text] [Related]
33. Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma.
Gabriel PE; Pinar U; Lenfant L; Parra J; Vaessen C; Mozer P; Chartier-Kastler E; Rouprêt M; Seisen T
World J Urol; 2023 Nov; 41(11):3001-3007. PubMed ID: 37676283
[TBL] [Abstract][Full Text] [Related]
34. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
35. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
[TBL] [Abstract][Full Text] [Related]
36. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
37. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.
Campi R; Cotte J; Sessa F; Seisen T; Tellini R; Amparore D; Mormile N; Gobert A; Mari A; Porpiglia F; Serni S; Minervini A; Rouprêt M
World J Urol; 2019 Nov; 37(11):2303-2311. PubMed ID: 31062121
[TBL] [Abstract][Full Text] [Related]
38. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
39. A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.
Leow JJ; Martin-Doyle W; Fay AP; Choueiri TK; Chang SL; Bellmunt J
Eur Urol; 2014 Sep; 66(3):529-41. PubMed ID: 24680361
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
Kim HS; Lee JS; Jeong CW; Kwak C; Kim HH; Ku JH
Int Braz J Urol; 2015; 41(6):1067-79. PubMed ID: 26742963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]